Coeliac Disease Trial, Recruiting NCT07326137 Sponsor: Tongji Hospital Condition: Coeliac Disease
Back to Coeliac Disease

Coeliac Disease Trial, Recruiting

NCT07326137
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with advanced cancer of the bile ducts, gallbladder, or pancreas, confirmed by a laboratory test on a tissue sample.
  • You have ongoing cancer-related pain that scores 4 or higher on a pain scale of 0–10, has lasted more than one week, and your doctors are planning a specific nerve-blocking procedure to help manage it.
  • You are scheduled to start a first course of cancer treatment, which may include immunotherapy on its own or combined with chemotherapy or targeted therapy.
  • You are able to carry out basic daily activities (with some limitations allowed) and your doctors estimate you have a life expectancy of at least 3 months.

Who may not be able to join:

  • You have previously had the nerve-blocking procedure (celiac plexus neurolysis or ablation) in the past.
  • Your blood does not clot properly, based on specific blood test results showing clotting or platelet levels outside safe ranges.
  • You have severe heart, liver, or kidney problems, as measured by specific medical assessments (confirm with trial site).
  • There is a reason why the nerve-blocking procedure would not be safe for you, such as a local infection or an unusual body structure in the relevant area.
  • You have any other health condition that the trial doctor believes would make it unsafe for you to take part.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13636076910

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tongji Hospital
Registry
ClinicalTrials.gov
Start date
26 December 2025
Est. completion
26 June 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Objective Response Rate (ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov